Assenagon Asset Management
ENZ

Assenagon Asset Management’s Enzo Biochem, Inc. ENZ Stock Holding History

Assenagon Asset Management’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-19,773
Closed -$21.6K – 1499
2024
Q2 		$21.6K Hold
19,773
– – ﹤0.01% 1401
2024
Q1 		$25.1K Sell
19,773
-52,643
-73% -$69.5K ﹤0.01% 1350
2023
Q4 		$101K Sell
72,416
-8,781
-11% -$11.6K ﹤0.01% 1386
2023
Q3 		$114K Sell
81,197
-100,665
-55% -$152K ﹤0.01% 1353
2023
Q2 		$335K Buy
181,862
+105,642
+139% +$245K ﹤0.01% 1213
2023
Q1 		$185K Buy
+76,220
New +$113K ﹤0.01% 1372
2022
Q3 		– Sell
-19,603
Closed -$41K – 1577
2022
Q2 		$41K Buy
+19,603
New +$48.5K ﹤0.01% 1428
2021
Q3 		– Sell
-11,793
Closed -$37K – 1458
2021
Q2 		$37K Buy
+11,793
New +$37.1K ﹤0.01% 1175
2019
Q2 		– Sell
-77,313
Closed -$211K – 1195
2019
Q1 		$211K Buy
77,313
+40,741
+111% +$133K ﹤0.01% 892
2018
Q4 		$102K Sell
36,572
-39,410
-52% -$129K ﹤0.01% 979
2018
Q3 		$313K Buy
+75,982
New +$345K ﹤0.01% 740

Other funds holding ENZ

HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WIM
Wittenberg Investment Management Carlisle, Massachusetts $269M AUM 28.17% 1-Year Est. Return

Assenagon Asset Management's ENZ Position: Q3 2024 in Review

Assenagon Asset Management sold out of Enzo Biochem, Inc. (ENZ) in Q3 2024, closing a stake of 19,773 shares — an estimated $21.6K sold.

Assenagon Asset Management first reported a position in ENZ in Q3 2018 and held it in 11 quarters. The position peaked at $335K in Q2 2023. 43 funds tracked by Wall St. Rank hold ENZ as of Q3 2024.

  • Assenagon Asset Management reported no remaining Enzo Biochem, Inc. position as of Q3 2024 after selling out during the quarter.
  • Assenagon Asset Management sold 19,773 Enzo Biochem, Inc. shares in Q3 2024, an estimated $21.6K.
  • Assenagon Asset Management first reported a position in Enzo Biochem, Inc. in Q3 2018 and held it in 11 quarters.
  • Assenagon Asset Management's Enzo Biochem, Inc. position peaked at $335K in Q2 2023.
  • 43 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q3 2024.

Based on Assenagon Asset Management's 13F filing for Q3 2024, filed 23 Oct 2024.